Editorial: New GPCR targets and modulators to treat CNS disorders

Front Mol Neurosci. 2022 Dec 6:15:1104336. doi: 10.3389/fnmol.2022.1104336. eCollection 2022.

Philippe De Deurwaerdère¹, Evgeni Ponimaskin², Abdeslam Chagraoui^{3

4}, Giuseppe Di Giovanni^{5

6}

¹ Centre National de la Recherche Scientifique, UMR 5287, Bordeaux, France.
² Neurophysiology, Hannover Medical School, Hannover, Germany.
³ Différenciation et Communication Neuroendocrine, Endocrine et Germinale (NorDic), INSERM U1239, IRIB, CHU Rouen, Rouen, France.
⁴ Department of Medical Biochemistry, Rouen University Hospital, Rouen, France.
⁵ Laboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
⁶ Neuroscience Division, School of Biosciences, Cardiff University, Cardiff, United Kingdom.

No abstract available

Keywords: G-protein coupled receptors; clinical pharmacology; heterodimer; molecular pharmacology; neurology; neuroscience; polypharmacology.

Publication types